Banned antibiotics behind 43% of shrimp export rejections; CDSCO seeks stricter enforcement
Banned Antibiotics Behind 43% of Shrimp Export Rejections; CDSCO Seeks Stricter Enforcement
Banned antibiotics behind 43 of shrimp - Indian shrimp exports face significant challenges due to the presence of banned antibiotics, which account for 43% of rejections by key markets such as the US, European Union, and Japan. According to the Central Drugs Standard Control Organisation (CDSCO), these residues in seafood products are a major concern for global buyers, prompting the country's drug regulator to intensify efforts to enforce stricter compliance with food safety standards. The issue has highlighted the need for enhanced monitoring and stricter penalties to address the growing problem of antibiotic misuse in aquaculture.
Key Banned Antibiotics and Their Impact
Among the prohibited antibiotics linked to export rejections, Chloramphenicol and Nitrofurans stand out as critical culprits. Chloramphenicol, a broad-spectrum antibiotic, is banned in food-producing animals because of its potential to cause chloramphenicol toxicity in humans, particularly in infants. Similarly, Nitrofurans are restricted for their carcinogenic properties and ability to persist in aquatic environments. These substances are often used in shrimp farming to prevent diseases, but their residues in the final product have led to repeated rejections from international buyers.
The CDSCO’s recent analysis reveals that Chloramphenicol and Nitrofurans are not only the most commonly detected banned antibiotics but also the primary reason for over 40% of export rejections. This has raised alarms within the aquaculture sector, as these violations threaten India’s reputation as a reliable supplier of seafood. The regulator has emphasized that such residues breach international standards, particularly those set by the World Health Organization and the Food and Agriculture Organization, which mandate strict limits on antibiotic use in food animals.
Regional Distribution of Violations
States like Andhra Pradesh, Odisha, West Bengal, and Gujarat have been identified as the epicenters of antibiotic misuse in shrimp farming. Andhra Pradesh alone contributed 46% of the violations, followed by Odisha (24%), West Bengal (19%), and Gujarat (11%). This geographical concentration suggests that certain regions may have weaker enforcement mechanisms or higher reliance on prohibited substances. The CDSCO has called for a coordinated approach to address these disparities, urging state governments to conduct regular inspections and ensure that farmers adhere to the prescribed limits.
Investigations into these farms have uncovered instances where banned antibiotics were sold through unlicensed channels or used in excess quantities to accelerate shrimp growth. The problem is compounded by the lack of awareness among small-scale养殖户 about the permissible levels of antibiotics and the consequences of their misuse. Experts warn that without immediate intervention, the export rejections could escalate, leading to financial losses and a decline in market share for Indian shrimp producers.
CDSCO’s Enforcement Measures
As part of its crackdown, the CDSCO has mandated that all states and Union Territories implement stringent monitoring protocols at veterinary drug outlets and shrimp farming units. This includes mandatory testing of water and feed for antibiotic residues, as well as stricter record-keeping for drug distribution. The regulator has also directed states to report quarterly data on inspections, violations, and corrective actions taken. These measures aim to create a transparent system that tracks antibiotic usage and ensures accountability at every stage of production.
Additionally, the CDSCO has proposed penalties under the Drugs and Cosmetics Act and Rules for repeat offenders. Violators may face fines, suspension of licenses, or even closure of their operations. The authority has also recommended the use of mobile testing units to conduct on-site checks in remote shrimp farming areas, where access to laboratories is limited. These steps are expected to reduce the incidence of banned antibiotics in the export supply chain and restore confidence among international buyers.
“The presence of these prohibited drugs in shrimp exports is not just a regulatory issue but a public health concern,” said a spokesperson for the Marine Products Export Development Authority (MPEDA). “We need to strengthen the link between veterinary medicine regulation and food safety standards to prevent future rejections.”
Industry stakeholders have welcomed the CDSCO’s directives but acknowledge the need for greater collaboration between regulatory bodies. MPEDA has emphasized that small-scale farmers, who form the backbone of India’s shrimp export industry, require targeted training and support to comply with international norms. Meanwhile, larger producers are already investing in advanced filtration systems and organic feed alternatives to minimize antibiotic dependency.
With the global seafood market becoming increasingly sensitive to antibiotic residues, India must balance its need for efficient disease control with the demands of food safety. The CDSCO’s focus on banned antibiotics behind 43% of shrimp export rejections underscores the urgency of this issue. As the nation’s shrimp exports continue to grow, the regulator’s efforts to enforce stricter measures will be crucial in maintaining quality and competitiveness in international markets.